132-98-9
132-98-9 結(jié)構(gòu)式
基本信息
青霉素 V 鉀
青霉素V鉀鹽
青霉素V鉀
PENICILLINE V POTASSIUM SALT
PENICILLIN V
PENICILLIN VK
PENICILLIN V POTASSIUM
PENICILLIN V POTASSIUM SALT
PHENOXYMETHYLPENICILLINIC ACID POTASSIUM SALT
PHENOXYMETHYLPENICILLIN K+ SALT
PHENOXYMETHYLPENICILLIN POTASSIUM
PHENOXYMETHYL PENICILLIN POTASSIUM SALT
4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylicacid,3,3-dimethyl-7-oxo-6-((ph
abicyclo[3.2.0]heptane-2-carboxylate
antibiocin
apsinvk
arcacil
arcasin
aspinvk
beromycin
beromycin(penicillin)
betapen-vk
物理化學(xué)性質(zhì)
安全數(shù)據(jù)
常見問題列表
Penicillin V (0.002-8.0 mg/L) inhibits the growth of
Streptococci
, with the minimum inhibitory concentrations (MICs) of 0.004-0.008 mg/L.
Penicillin V (0.002-8.0 mg/L) inhibits the growth of
C. difficile
, with a MIC
90
of 8 mg/L.
Penicillin V (0.004-0.063 mg/L; 18 h) inhibits the growth of
Staphylococcus aureus
, with a MIC of 0.016 mg/L.
Penicillin V (0.063-0.25 mg/kg; a single s.c.) inhibits the outgrowth of
S. aureus
in mice thigh muscle.
Penicillin V (100 mg/kg; p.o. once daily for 5 d) avoids the fulminant infection of acute purulent otitis media (AOM) in rats.
Penicillin V (2 mg/kg; a single s.c.) exhibits the plasma half-life (61 min) and mean AUC (0.47 mg/L?h).
| Animal Model: | Specific pathogen free (SPF) male Swiss mice (20-25 g) are inoculated S. aureus |
| Dosage: | 0.063, 0.13, 0.25 mg/kg |
| Administration: | A single s.c. |
| Result: | Decreased the number of CFU (1.34×10 7 counts/mL) compared to controls (3.5×10 7 counts/mL) at the dose of 0.25 mg/kg. |
| 報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
| 2024/11/11 | XW13298901 | 青霉素V鉀鹽 | 132-98-9 | 100G | 2671元 |
| 2024/11/08 | 45523 | 青霉素V鉀 Penicillin V potassium salt, 94+%, Thermo Scientific Chemicals | 132-98-9 | 5g | 567元 |
| 2024/11/08 | 45523 | 青霉素V鉀 Penicillin V potassium salt, 94+%, Thermo Scientific Chemicals | 132-98-9 | 25g | 1941元 |